FDA approves Regeneron asthma drug
October 22, 2018 at 14:54 PM EDT
Regeneron Pharmaceuticals was awarded federal approval Friday to market its Dupixent drug to treat patients with moderate to severe asthma.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|